Skip to content

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05022667
Enrollment
114
Registered
2021-08-26
Start date
2021-12-01
Completion date
2024-05-31
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, Hypoparathyroidism, Neoplasms, Neoplasms by Site, Parathyroid Diseases, Thyroid Diseases, Thyroid Neoplasms

Keywords

Total Thyroidectomy, Intraoperative Parathyroid Identification, Near Infrared Autofluorescence, Postoperative Hypocalcemia, Postoperative Hypoparathyroidism

Brief summary

This study will see if the use of near infrared autofluorescence (NIRAF) detection with a 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx) is better than surgeon's detection alone. It compares risk, benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

Detailed description

Prior to data collection, it was determined some additional outcome measures collected by the primary site would not be relevant to the trial for participating sites such as this site. Those outcomes were removed from this record.

Interventions

DEVICEPTeye

The surgeon will first take 5 baseline NIRAF measurements on the thyroid gland (or neck muscle, if thyroid is absent) using the disposable sterile fiber probe that is connected to the PTeye console, as per device functionality requirements.

Sponsors

Vanderbilt University
CollaboratorOTHER
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with thyroid disease who will be undergoing total thyroidectomy (includes patients who have undergone a prior neck exploration for parathyroid disease or other but have an intact thyroid gland). * Patients with persisting thyroid disease and will be undergoing re-operative or completion thyroidectomy.

Exclusion criteria

* Pregnant women * Patients with concurrent parathyroid and thyroid disease * Patients with incidental enlarged parathyroid discovered during thyroidectomy procedure. * Patients undergoing thyroid lobectomy or partial thyroidectomy

Design outcomes

Primary

MeasureTime frameDescription
The Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per PatientImmediate (During total thyroidectomy procedure)Overall number of parathyroid glands identified (Experimental Group: Glands identified with naked eye + NIRAF; Control Group: Glands identified with naked eye)

Secondary

MeasureTime frameDescription
Blood Parathyroid Hormone (PTH) Levels at 24-48 Hours After SurgeryWithin 24-48 hours after surgeryBlood parathyroid hormone (PTH) levels at 24-48 hours after surgery
Blood Calcium Levels 24-48 Hours After SurgeryWithin 24-48 hours after surgeryBlood calcium levels 24-48 hours after surgery
Duration in Minutes of SurgeryCollected immediately following surgeryDuration of surgery (minutes)
Blood Parathyroid Hormone (PTH) Levels at 5-14 Days After Surgery5-14 days after surgeryBlood parathyroid hormone (PTH) levels at 5-14 days post-op
Number of Auto-transplanted Parathyroid GlandsImmediate. During total thyroidectomy procedureNumber of auto-transplanted parathyroid glands if the parathyroid gland was accidentally excised/devascularized.
Number of Nights Spent in the Hospital After Total Thyroidectomy0 - 4 nights after total thyroidectomyNumber of nights spent for postoperative recovery in the hospital after the surgical procedure.
Number of Inadvertently Resected Parathyroid GlandsImmediate (intraoperative) to 7-10 days after total thyroidectomy (as presented in the pathology report)Number of inadvertently resected parathyroid glands when parathyroid tissue is found in the resected thyroid specimens. Results reflect the participants who had an inadvertently resected parathyroid gland.
Number of Frozen Section Analysis Performed.Collected immediately following surgeryNumber of frozen section analysis performed. Samples of a suspected piece of parathyroid tissue were removed and analyzed to confirm whether they were actually parathyroid tissue. Results reflect the participants who were determined to have had a frozen section conducted.

Countries

United States

Participant flow

Participants by arm

ArmCount
PTeye
The surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the total thyroidectomy procedure. PTeye: The surgeon will first take 5 baseline NIRAF measurements on the thyroid gland (or neck muscle, if thyroid is absent) using the disposable sterile fiber probe that is connected to the PTeye console, as per device functionality requirements.
57
Standard of Care
The surgeon will not use the PTeye and will proceed with the total thyroidectomy as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations.
57
Total114

Baseline characteristics

CharacteristicPTeyeTotalStandard of Care
Age, Continuous51.2 years
STANDARD_DEVIATION 16.9
51.9 years
STANDARD_DEVIATION 16.4
52.6 years
STANDARD_DEVIATION 16
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants5 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
54 Participants109 Participants55 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Final Diagnosis
Goiters and nodular diseases
13 Participants19 Participants6 Participants
Final Diagnosis
Grave's disease
18 Participants33 Participants15 Participants
Final Diagnosis
Thyroid cancer
26 Participants62 Participants36 Participants
Preoperative calcium (pg/dL)9.4 (pg/dL)
STANDARD_DEVIATION 0.5
9.5 (pg/dL)
STANDARD_DEVIATION 0.5
9.5 (pg/dL)
STANDARD_DEVIATION 0.4
Preoperative PTH (pg/mL)48.2 (pg/mL)
STANDARD_DEVIATION 22.4
64.6 (pg/mL)
STANDARD_DEVIATION 27.9
78.3 (pg/mL)
STANDARD_DEVIATION 25
Preoperative vitamin D (mcg)33 mcg
STANDARD_DEVIATION 13.6
30.9 mcg
STANDARD_DEVIATION 12
29.3 mcg
STANDARD_DEVIATION 11
Race/Ethnicity, Customized
Asian
3 Participants7 Participants4 Participants
Race/Ethnicity, Customized
Black
4 Participants7 Participants3 Participants
Race/Ethnicity, Customized
Other
3 Participants4 Participants1 Participants
Race/Ethnicity, Customized
White
47 Participants96 Participants49 Participants
Region of Enrollment
United States
57 Participants114 Participants57 Participants
Sex: Female, Male
Female
44 Participants87 Participants43 Participants
Sex: Female, Male
Male
13 Participants27 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 570 / 57
other
Total, other adverse events
0 / 570 / 57
serious
Total, serious adverse events
0 / 570 / 57

Outcome results

Primary

The Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per Patient

Overall number of parathyroid glands identified (Experimental Group: Glands identified with naked eye + NIRAF; Control Group: Glands identified with naked eye)

Time frame: Immediate (During total thyroidectomy procedure)

ArmMeasureValue (MEAN)
PTeyeThe Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per Patient3.1 parathyroid glands per patient
Standard of CareThe Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per Patient2.9 parathyroid glands per patient
p-value: 0.3t-test, 2 sided
Secondary

Blood Calcium Levels 24-48 Hours After Surgery

Blood calcium levels 24-48 hours after surgery

Time frame: Within 24-48 hours after surgery

Population: Not all participants returned for this lab assessment during the 24-48 hour data collection period. As such, no data for these participants was collected.

ArmMeasureValue (MEAN)Dispersion
PTeyeBlood Calcium Levels 24-48 Hours After Surgery9.4 pg/dLStandard Deviation 0.5
Standard of CareBlood Calcium Levels 24-48 Hours After Surgery9.3 pg/dLStandard Deviation 0.5
p-value: 0.3t-test, 2 sided
Secondary

Blood Parathyroid Hormone (PTH) Levels at 24-48 Hours After Surgery

Blood parathyroid hormone (PTH) levels at 24-48 hours after surgery

Time frame: Within 24-48 hours after surgery

Population: Not all participants returned for this lab assessment during the 24-48 hour data collection period. As such, no data for these participants was collected.

ArmMeasureValue (MEAN)Dispersion
PTeyeBlood Parathyroid Hormone (PTH) Levels at 24-48 Hours After Surgery20.7 pg/mLStandard Deviation 11.6
Standard of CareBlood Parathyroid Hormone (PTH) Levels at 24-48 Hours After Surgery24.3 pg/mLStandard Deviation 16.6
p-value: 0.2t-test, 2 sided
Secondary

Blood Parathyroid Hormone (PTH) Levels at 5-14 Days After Surgery

Blood parathyroid hormone (PTH) levels at 5-14 days post-op

Time frame: 5-14 days after surgery

Population: Not all participants returned for this lab assessment during the 5-14 day data collection period. As such, no data for these participants was collected.

ArmMeasureValue (MEAN)Dispersion
PTeyeBlood Parathyroid Hormone (PTH) Levels at 5-14 Days After Surgery35.6 pg/mLStandard Deviation 25.3
Standard of CareBlood Parathyroid Hormone (PTH) Levels at 5-14 Days After Surgery41 pg/mLStandard Deviation 34.7
p-value: 0.5t-test, 2 sided
Secondary

Duration in Minutes of Surgery

Duration of surgery (minutes)

Time frame: Collected immediately following surgery

ArmMeasureValue (MEAN)Dispersion
PTeyeDuration in Minutes of Surgery126.2 minutesStandard Deviation 39.6
Standard of CareDuration in Minutes of Surgery120.3 minutesStandard Deviation 34.7
p-value: 0.4t-test, 2 sided
Secondary

Number of Auto-transplanted Parathyroid Glands

Number of auto-transplanted parathyroid glands if the parathyroid gland was accidentally excised/devascularized.

Time frame: Immediate. During total thyroidectomy procedure

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
PTeyeNumber of Auto-transplanted Parathyroid Glands041 Participants
PTeyeNumber of Auto-transplanted Parathyroid Glands116 Participants
PTeyeNumber of Auto-transplanted Parathyroid Glands2 or more0 Participants
Standard of CareNumber of Auto-transplanted Parathyroid Glands046 Participants
Standard of CareNumber of Auto-transplanted Parathyroid Glands110 Participants
Standard of CareNumber of Auto-transplanted Parathyroid Glands2 or more1 Participants
p-value: 0.3Chi-squared
Secondary

Number of Frozen Section Analysis Performed.

Number of frozen section analysis performed. Samples of a suspected piece of parathyroid tissue were removed and analyzed to confirm whether they were actually parathyroid tissue. Results reflect the participants who were determined to have had a frozen section conducted.

Time frame: Collected immediately following surgery

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
PTeyeNumber of Frozen Section Analysis Performed.055 Participants
PTeyeNumber of Frozen Section Analysis Performed.1 or more2 Participants
Standard of CareNumber of Frozen Section Analysis Performed.055 Participants
Standard of CareNumber of Frozen Section Analysis Performed.1 or more2 Participants
Secondary

Number of Inadvertently Resected Parathyroid Glands

Number of inadvertently resected parathyroid glands when parathyroid tissue is found in the resected thyroid specimens. Results reflect the participants who had an inadvertently resected parathyroid gland.

Time frame: Immediate (intraoperative) to 7-10 days after total thyroidectomy (as presented in the pathology report)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PTeyeNumber of Inadvertently Resected Parathyroid Glands5 Participants
Standard of CareNumber of Inadvertently Resected Parathyroid Glands5 Participants
Secondary

Number of Nights Spent in the Hospital After Total Thyroidectomy

Number of nights spent for postoperative recovery in the hospital after the surgical procedure.

Time frame: 0 - 4 nights after total thyroidectomy

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
PTeyeNumber of Nights Spent in the Hospital After Total Thyroidectomy0 nights0 Participants
PTeyeNumber of Nights Spent in the Hospital After Total Thyroidectomy1 night57 Participants
PTeyeNumber of Nights Spent in the Hospital After Total Thyroidectomy> 1 night0 Participants
Standard of CareNumber of Nights Spent in the Hospital After Total Thyroidectomy0 nights0 Participants
Standard of CareNumber of Nights Spent in the Hospital After Total Thyroidectomy1 night57 Participants
Standard of CareNumber of Nights Spent in the Hospital After Total Thyroidectomy> 1 night0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026